Suzhou Zelgen BiopharmaceuticalsLtd Future Growth
Future criteria checks 5/6
Suzhou Zelgen BiopharmaceuticalsLtd is forecast to grow earnings and revenue by 115.7% and 58.7% per annum respectively. EPS is expected to grow by 115.6% per annum. Return on equity is forecast to be 11.1% in 3 years.
Key information
115.7%
Earnings growth rate
115.6%
EPS growth rate
| Biotechs earnings growth | 39.5% |
| Revenue growth rate | 58.7% |
| Future return on equity | 11.1% |
| Analyst coverage | Low |
| Last updated | 10 Sep 2024 |
Recent future growth updates
Recent updates
Some Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHSE:688266) Analysts Just Made A Major Cut To Next Year's Estimates
Sep 11
What Does The Future Hold For Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHSE:688266)? These Analysts Have Been Cutting Their Estimates
May 08Suzhou Zelgen Biopharmaceuticals Co.,Ltd.'s (SHSE:688266) Shares Climb 28% But Its Business Is Yet to Catch Up
Mar 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,933 | 357 | -303 | 310 | 4 |
| 12/31/2025 | 1,219 | 47 | -492 | -102 | 4 |
| 12/31/2024 | 624 | -205 | -307 | -237 | 4 |
| 6/30/2024 | 407 | -231 | -69 | 14 | N/A |
| 3/31/2024 | 387 | -261 | -186 | -113 | N/A |
| 12/31/2023 | 386 | -279 | -295 | -233 | N/A |
| 9/30/2023 | 387 | -296 | -377 | -319 | N/A |
| 6/30/2023 | 417 | -325 | -419 | -345 | N/A |
| 3/31/2023 | 367 | -395 | -423 | -341 | N/A |
| 12/31/2022 | 302 | -457 | -459 | -370 | N/A |
| 9/30/2022 | 290 | -522 | -499 | -407 | N/A |
| 6/30/2022 | 253 | -521 | -490 | -399 | N/A |
| 3/31/2022 | 234 | -491 | -494 | -411 | N/A |
| 12/31/2021 | 190 | -451 | -525 | -455 | N/A |
| 9/30/2021 | 98 | -384 | -518 | -449 | N/A |
| 6/30/2021 | 70 | -368 | -465 | -400 | N/A |
| 3/31/2021 | 28 | -337 | -435 | -370 | N/A |
| 12/31/2020 | 28 | -319 | -402 | -344 | N/A |
| 9/30/2020 | 28 | -292 | -318 | -271 | N/A |
| 6/30/2020 | N/A | -249 | -276 | -250 | N/A |
| 3/31/2020 | N/A | -354 | -234 | -215 | N/A |
| 12/31/2019 | N/A | -462 | -196 | -180 | N/A |
| 9/30/2019 | N/A | -747 | -166 | -155 | N/A |
| 12/31/2018 | 1 | -440 | -124 | -112 | N/A |
| 12/31/2017 | N/A | -146 | N/A | -108 | N/A |
| 12/31/2016 | 0 | -128 | N/A | -57 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688266 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 688266 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 688266 is expected to become profitable in the next 3 years.
Revenue vs Market: 688266's revenue (58.7% per year) is forecast to grow faster than the CN market (13.2% per year).
High Growth Revenue: 688266's revenue (58.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688266's Return on Equity is forecast to be low in 3 years time (11.1%).